Parul Agarwal

5PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 23, 2025
A Phase II Study of Neoadjuvant GVAX and Cyclophosphamide Combined with Nivolumab and SBRT Followed by Surgery in Borderline Resectable Pancreatic Adenocarcinoma.

Parul Agarwal, Matthew Guo, Kabeer Munjal

|Apr 25, 2024
Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors.

Chirayu Mohindroo, Seyda Baydogan, Parul Agarwal

|Nov 28, 2023
Immunotherapy of MSI Cancer: Facts and Hopes.

H Catherine Wilbur, Dung T Le, Parul Agarwal

|Mar 27, 2023
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma.

Eric S Christenson, Su Jin Lim, Jennifer Durham

Pageof 1